About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Lab Mice Are Being Kept Too Cold, Apparently | Main | More Worthless Press Releases »

December 18, 2013

Press Release Fraud - The Verdict Stands

Email This Entry

Posted by Derek

The Harkonen/Intermune case (blogged about here) seems to have come to a resolution (or no resolution, depending on your viewing angle): the Supreme Court has declined to hear W. Scott Harkonen's appeal. So the original verdict (and the rejection of its appeal) stand, and the argument that the disputed press release was merely a scientific argument fails. I agree with that, because this case seemed pretty egregious, but it might have been nice to see what the Supreme Court thought about the issue. The problem is, when you invite that, you get to, well, find out what the Supreme Court thinks about the issue. And like the old Fleetwood Mac song, "Oh, Well", they might not give the answer that you want them to.

I wanted to mention, since I linked to the Pharmalot article on this, that it appears that the whole PharmaLive/Med Ad News/Pharmalot operation is being shut down as of the end of this year. As soon as I hear what Ed Silverman, Pharmalot's longtime author, is up to after this, I'll make a note of it on the blog.

Comments (6) + TrackBacks (0) | Category: The Dark Side


1. The Aqueous Layer on December 18, 2013 11:26 AM writes...

Christiane Truelove, a Content Director at the UBM Canon Pharmaceutical Media Group, and Ed's Pharmalot fill-in when he is out of the office, did say this on Twitter a few days ago...

Yes, it is true Med Ad News/Pharmalive/Pharmalot are being discontinued as of Dec. 31. It's been a great 14 years.

Permalink to Comment

2. anon the II on December 18, 2013 11:39 AM writes...

That is old Fleetwood Mac, Peter Green stuff from the late '60s.

Permalink to Comment

3. Bernard Munos on December 18, 2013 11:50 AM writes...

Sad news for Pharmalot. Has been part of my daily read for years. I will miss it. Hope Ed Silberman reincarnates into a new and better version.

Permalink to Comment

4. NJBiologist on December 18, 2013 4:24 PM writes...

@3 Bernard Munos--I agree. What does it say that neither the Newark Star-Ledger nor Pharmalive could keep the site going?

Permalink to Comment

5. pgwu on December 18, 2013 5:41 PM writes...

Based on this blog It seems more than Pharmalot are to be closed. I'll miss reading it too.

Permalink to Comment

6. Nick Mavrogenes on January 3, 2014 1:55 PM writes...

The first thing I would do in the morning is grab my "cup of stimulation" and read pharmalot. It is like the loss of an old friend.

Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry